Bachem Holding AG

LSE:0QND.LHealthcare

——At close · Market cap — · Next earnings Thu 4 Mar

CHF millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	402.0	503.2	531.7	577.3	605.3	695.1	+14.8%
Cost of revenue	273.1	336.5	360.5	400.4	422.7	495.3	+17.2%
Gross profit	128.9	166.7	171.3	177.0	182.6	199.7	+9.4%
Research & development	2.9	3.8	7.2	11.0	11.4	10.2	−10.1%
Selling, general & administrative	30.2	34.9	37.8	37.4	39.2	39.2	−0.0%
Selling & marketing	15.6	18.0	18.8	18.0	0.0	0.0	—
Operating expenses	33.1	38.7	45.0	47.6	50.6	49.4	−2.3%
Operating income	95.8	128.0	126.3	129.4	131.9	150.3	+13.9%
Interest expense	0.6	0.8	0.7	0.4	0.3	0.5	+65.8%
Interest income	0.0	0.0	0.0	1.7	1.1	0.3	−77.5%
Other income / expense	(4.8)	2.5	(14.2)	(5.2)	3.3	6.1	+87.2%
Pre-tax income	91.0	131.4	112.1	124.2	135.2	156.4	+15.7%
Income tax	12.9	16.7	11.4	12.3	15.0	7.6	−49.2%
Net income	78.1	114.7	100.7	111.9	120.2	148.8	+23.7%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	1.12	1.62	1.37	1.50	1.60	1.98	+23.7%
EPS, diluted (per share)	1.12	1.62	1.37	1.50	1.60	1.98	+23.7%
EBITDA	117.5	160.6	146.1	163.3	178.8	189.9	+6.2%
Depreciation & amortization	25.9	28.4	33.3	33.9	43.3	39.6	−8.5%
Weighted average shares (shares)	69,986,140	70,846,745	73,734,613	74,688,455	74,980,412	74,961,792	−0.0%
Weighted average diluted shares (shares)	69,986,140	70,846,745	73,734,613	74,688,455	74,980,412	74,961,792	−0.0%
Gross margin	32.1%	33.1%	32.2%	30.7%	30.2%	28.7%	−1.4 pts
Operating margin	23.8%	25.4%	23.8%	22.4%	21.8%	21.6%	−0.2 pts
Net margin	19.4%	22.8%	18.9%	19.4%	19.9%	21.4%	+1.5 pts

CHF millionsUpdated 31 Dec 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.